Skip to main content
logo
Kukje Pharma Co., Ltd. (KRX:002720)
South Korea flag South Korea · Delayed Price · Currency is KRW
3,435.00
+50.00 (1.48%)
Sep 1, 2026, 3:30 PM KST

Kukje Pharma Financials Overview

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
181,267175,496156,463135,373126,583119,746
Revenue Growth
8.02%12.16%15.58%6.94%5.71%-8.17%
Gross Profit
97,25593,64582,49567,22563,25454,470
Operating Income
4,4756,1856,702-1,9895,273-1,676
Net Income
5,0015,6985,205-8,4153,557-1,559
Earnings Per Share
240.18279.51256.00-415.49175.58-77.14
EPS Growth
-23.55%9.18%----

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
15,72210,7248,75510,6325,5597,903
Total Debt
31,38730,40429,51230,66228,59635,987
Net Cash (Debt)
-15,665-19,680-20,757-20,030-23,037-28,084
Net Cash Growth
------
Net Cash Per Share
-752.33-965.47-1020.85-988.96-1137.06-1385.71

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
6,6915,8353,9403,5756,5049,597
Capital Expenditures
-4,366-3,619-2,911-1,046-1,259-1,892
Free Cash Flow
2,3252,2161,0292,5295,2457,705
Free Cash Flow Growth
-64.67%115.42%-59.32%-51.78%-31.93%-

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
53.65%53.36%52.73%49.66%49.97%45.49%
Operating Margin
2.47%3.52%4.28%-1.47%4.17%-1.40%
Pretax Margin
3.13%3.67%4.22%-4.93%3.75%-0.93%
Profit Margin
2.76%3.25%3.33%-6.22%2.81%-1.30%
FCF Margin
1.28%1.26%0.66%1.87%4.14%6.43%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
14.0915.3719.80-29.83-
P/FCF Ratio
29.6539.51100.1447.4020.2314.65
PS Ratio
0.380.500.660.890.840.94